Skip to content
Back to Investors
D

Deepbridge

Venture Capital

Early-stage life science investors supporting growth-focused companies through sector-specific enterprise investment schemes.


Recent investments

Growth
£18.2M

The funding round was led by Toscafund Asset Management with support from Deepbridge Capital, and will fund international expansion and product development.

"As market practitioners we have always been acutely aware of market developments and working with market participants to shape our product development and innovation. As such it was important, we found a partner who shared our vision within financial services. We believe that Toscafund’s global expertise and impressive market connectivity will be of tremendous benefit to VoxSmart in our next stage of growth."
— Oliver Blower, CEO
Growth
£1.0M

The early cancer diagnostic specialist received backing from existing investor Deepbridge Capital alongside leadership changes.

"I am delighted and look forward to working with Martin. We both share the passion for growing businesses which make a difference in people’s lives. These are exciting times as we forge our plans for Zilico"
— Sameer Kothari, Chief Executive
Series A
£1.5M

Deepbridge Capital led the Series A round with participation from the Development Bank of Wales to accelerate expansion into the US market.

"Deepbridge is committed to fostering innovation and growth in businesses with truly disruptive market potential, and we believe that Thalia definitely falls into that category,"
— Ray Eugeni, Partner
Series A
£2.0M

Deepbridge Capital has backed Touch Biometrix in a Series A round to support the commercialisation of its fingerprint sensor technology.

"This new and substantial investment from Deepbridge will enable Touch Biometrix to build upon its development work with the aim of defining its first minimum viable product ahead of scaled product in early 2020."
— Mike Cowin, CEO